von Spreckelsen, N., Waldt, N., Poetschke, R., Kesseler, C., Dohmen, H., Jiao, H., . . . Mawrin, C. (2020). KLF4(K409Q)–mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment. Acta Neuropathol Commun.
Dyfyniad Arddull Chicagovon Spreckelsen, Niklas, et al. "KLF4(K409Q)–mutated Meningiomas Show Enhanced Hypoxia Signaling and Respond to MTORC1 Inhibitor Treatment." Acta Neuropathol Commun 2020.
Dyfyniad MLAvon Spreckelsen, Niklas, et al. "KLF4(K409Q)–mutated Meningiomas Show Enhanced Hypoxia Signaling and Respond to MTORC1 Inhibitor Treatment." Acta Neuropathol Commun 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.